AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

A father-of-three who was initially told his rib and back pain was likely caused by a pulled muscle was left in “complete ...

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Experts hope the test will enable doctors to pick up early signs of the deadly disease, which can have vague or no symptoms.